And
AccuraMedizintechnik GmbHMaz-Planck-Strabe 33
61184 Karben, Germany.
INTERODUCING FIRST TIME IN PAKISTAN.
THE WORLD’S
FIRST DRUG ELUTINGACCURA STENT
ABN INTERNATIONAL AND ACCURA
AT ACCURA MEDICAL,DISESASE IS OUR TRUE CONPITITION
ACCURA DES Stent is our least weapon against a growing epidemic
Paclitaxel-Coated-Eluting Stent System
1. Coated with DLC (Diamond Like Carbon) for long term biocompatibility and covered with Polymer & Paclitaxel for slow release within 30 days.
2. High mechanical stability of the coating3. Star-shaped segments with flexible links to follow
vessel movements
Technical Specifications:Stent: Stainless steelDrug: Paclitaxel 1μg/mm²Coating Thickness: 1-2μmRelease kinetic:Slow release within 10-28 daysStent Surface finishing:DLC Pll (plasma ion implantation)Polymer:Inert polymer compound/ fully restorable.
A C C U R AMedizintechnik GmbH
Available Sizes,
27 Million
People Suffer from Peripheral Arterial Disease.
Also Known as PAD.
Smoking increases the risk of PAD by
2 to 4X
It is estimated that
20 %
Of people with PAD will suffer a non-fatal heart attack or stroke.
And nearly
30 %
Will die within
5 Year
A potential consequence of PAD is.
Amputation
With an annual aftercare Cost per patient of
$ 49,000
Rs. 3900000
And an average life expectancy after lower-limb amputation of
5 Years
The annual cost of aftercare for a PAD patient whose amputation has been prevented.
$ 800
Rs.160000
Thanks
Causes of PAD
Diabetes.
increasing14 % Annually
High Blood
Pressure
Causes of PAD
Causes Of PAD.H
igh
Cholester
ol
Causes of PAD
And Weighing
30 % More then
your ideal weight.
25%
Of the world’s
population
Which
includes:
#1Way to improve health.
Exercise.
Exercise.
2 of the leading reasons people avoid exercise and physical activity.
1)Lack of energy.
2)Leg pain and discomfort.
2 early symptoms of PAD
And so the cycle continues,
Introducing
A C C U R AMedizintechnik GmbHDrug-Eluting Stent
www.accuramed.de